Big pharma did not run antidepressant drug trials on children at first stating safety concerns. However, when they were told their drugs can stay on the market an additional 6 months before generic forms would be available, suddenly the issue of safety concerns in children disappeared. An additional 6 months is equivalent to billions mor…
Big pharma did not run antidepressant drug trials on children at first stating safety concerns. However, when they were told their drugs can stay on the market an additional 6 months before generic forms would be available, suddenly the issue of safety concerns in children disappeared. An additional 6 months is equivalent to billions more in profit.
I work on addressing endogenous imbalances. The problem is, this takes time and the client needs be an active participant. Most people still just want a pill, a quick fix, and will never find resolution. The medical model is too deeply engrained in the public.
Big pharma did not run antidepressant drug trials on children at first stating safety concerns. However, when they were told their drugs can stay on the market an additional 6 months before generic forms would be available, suddenly the issue of safety concerns in children disappeared. An additional 6 months is equivalent to billions more in profit.
I work on addressing endogenous imbalances. The problem is, this takes time and the client needs be an active participant. Most people still just want a pill, a quick fix, and will never find resolution. The medical model is too deeply engrained in the public.